ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Drug-Device Combination Products Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-33L12123
Home | Market Reports | Health| Medical Devices & Equipment
Global Drug Device Combination Products Industry Research Report Growth Trends and Competitive Analysis 2022 2028
BUY CHAPTERS

Global Drug-Device Combination Products Market Research Report 2025

Code: QYRE-Auto-33L12123
Report
March 2025
Pages:102
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Medtronic Inc
Boston Scientific
BD
Teleflex
Terumo
GSK
Novo Nordisk
Eli Lilly
Astrazeneca plc
Sanofi
Abbott
Boehringer Ingelheim
3M
Hisamitsu
Smith & Nephew
Molnlycke
Lepu Medical
MicroPort
B. Braun
Antares Pharma
Viatris

Drug-Device Combination Products Market Size

The global market for Drug-Device Combination Products was valued at US$ 40460 million in the year 2024 and is projected to reach a revised size of US$ 61280 million by 2031, growing at a CAGR of 6.2% during the forecast period.

Drug-Device Combination Products Market

Drug-Device Combination Products Market

Combination products are therapeutic and diagnostic products that combine drugs, devices and/or biological products, leading to safer and more effective treatments thanks to careful and precise drug targeting, local administration and individualized therapy. These technologies can especially benefit patients suffering from serious diseases and conditions such as cancer, heart disease, multiple sclerosis and diabetes, among others. On the other hand, drug-device combination products have also introduced a new dynamic in medical product development, regulatory approval and corporate interaction.
Drivers of the Drug-Device Combination Products Market:
Growing Prevalence of Chronic Diseases: The rising incidence of chronic conditions such as diabetes, cardiovascular diseases, and respiratory disorders is fueling demand for drug-device combination products. These products, which combine medications with devices (like insulin pens or inhalers), offer more effective and patient-friendly treatment options.
Technological Advancements: Innovations in drug delivery technologies (e.g., smart drug delivery systems, micro-needles, and wearable injectors) have enhanced the efficiency and convenience of combination products. These innovations improve patient compliance and the precision of drug administration, driving market growth.
Increasing Geriatric Population: The global rise in the elderly population leads to greater demand for combination products. The elderly are more likely to suffer from multiple chronic conditions that require complex treatment regimes, which are often easier to manage with combination products.
Shift to Self-administration: Drug-device combination products enable patients to administer their medication at home, reducing the need for frequent hospital visits. This trend is particularly relevant during public health crises, like the COVID-19 pandemic, and supports growth in this market.
Regulatory Support: Regulatory authorities such as the FDA have provided specific pathways and guidance for the approval of drug-device combination products. This clarity supports product development and market entry.
Challenges in the Drug-Device Combination Products Market:
Complex Regulatory Approval Process: Despite some regulatory support, obtaining approval for drug-device combination products can be challenging. These products must meet both drug and device regulations, leading to potentially longer approval times and higher costs.
High Development Costs: The integration of drugs and devices often requires substantial investment in research, development, and clinical trials. This can be a barrier for smaller companies or startups trying to enter the market.
Risk of Product Recalls: Combination products are subject to the risks associated with both drugs and devices, such as manufacturing defects, quality issues, and adverse events. A problem with one component can lead to recalls, damaging a company’s reputation and finances.
Reimbursement and Pricing Issues: Securing reimbursement for combination products can be complex due to their dual nature. Payers may not readily classify or cover these products under standard reimbursement schemes, creating pricing challenges.
Patient Education and Compliance: Despite the benefits of self-administration, patients may struggle with proper use of combination products, leading to poor outcomes or misuse. Ensuring that patients are adequately educated about their use is a significant challenge.
Global key drug-device combination products players include GSK, Novo Nordisk and Eli Lilly etc. The top 3 companies hold a share about 32%. North America is the largset market with a share about 42%, followed by Europe and Asia-Pacific. In terms of product, nebulizer & inhaler is the largest segment with a share about 36%. And in terms of applications, the largset application is hospital and clinic with a share about 47%.
This report aims to provide a comprehensive presentation of the global market for Drug-Device Combination Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug-Device Combination Products.
The Drug-Device Combination Products market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug-Device Combination Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug-Device Combination Products companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Drug-Device Combination Products Market Report

Report Metric Details
Report Name Drug-Device Combination Products Market
Accounted market size in year US$ 40460 million
Forecasted market size in 2031 US$ 61280 million
CAGR 6.2%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospital andClinic
  • Retail Pharmacies
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company GSK, Novo Nordisk, Eli Lilly, AstraZeneca, Sanofi, Boston Scientific, Abbott, Boehringer Ingelheim, Medtronic, Viatris, 3M, Hisamitsu, Smith & Nephew, Molnlycke, Teleflex, BD, Lepu Medical, MicroPort, Terumo, B. Braun, Antares Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Drug-Device Combination Products company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Drug-Device Combination Products Market growing?

Ans: The Drug-Device Combination Products Market witnessing a CAGR of 6.2% during the forecast period 2025-2031.

What is the Drug-Device Combination Products Market size in 2031?

Ans: The Drug-Device Combination Products Market size in 2031 will be US$ 61280 million.

What is the market share of major companies in Drug-Device Combination Products Market?

Ans: The top 3 companies hold a share about 32%.

Who are the main players in the Drug-Device Combination Products Market report?

Ans: The main players in the Drug-Device Combination Products Market are GSK, Novo Nordisk, Eli Lilly, AstraZeneca, Sanofi, Boston Scientific, Abbott, Boehringer Ingelheim, Medtronic, Viatris, 3M, Hisamitsu, Smith & Nephew, Molnlycke, Teleflex, BD, Lepu Medical, MicroPort, Terumo, B. Braun, Antares Pharma

What are the Application segmentation covered in the Drug-Device Combination Products Market report?

Ans: The Applications covered in the Drug-Device Combination Products Market report are Hospital andClinic, Retail Pharmacies, Other

What are the Type segmentation covered in the Drug-Device Combination Products Market report?

Ans: The Types covered in the Drug-Device Combination Products Market report are Drug-Coated Device, Prefilled Drug Delivery Systems, Nebulizer and Inhaler, Transdermal Delivery System, Others

Recommended Reports

Drug Delivery Devices

Diabetes & Injection

Therapy & Treatment

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug-Device Combination Products Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Drug-Coated Device
1.2.3 Prefilled Drug Delivery Systems
1.2.4 Nebulizer and Inhaler
1.2.5 Transdermal Delivery System
1.2.6 Others
1.3 Market by Application
1.3.1 Global Drug-Device Combination Products Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital andClinic
1.3.3 Retail Pharmacies
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug-Device Combination Products Market Perspective (2020-2031)
2.2 Global Drug-Device Combination Products Growth Trends by Region
2.2.1 Global Drug-Device Combination Products Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Drug-Device Combination Products Historic Market Size by Region (2020-2025)
2.2.3 Drug-Device Combination Products Forecasted Market Size by Region (2026-2031)
2.3 Drug-Device Combination Products Market Dynamics
2.3.1 Drug-Device Combination Products Industry Trends
2.3.2 Drug-Device Combination Products Market Drivers
2.3.3 Drug-Device Combination Products Market Challenges
2.3.4 Drug-Device Combination Products Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug-Device Combination Products Players by Revenue
3.1.1 Global Top Drug-Device Combination Products Players by Revenue (2020-2025)
3.1.2 Global Drug-Device Combination Products Revenue Market Share by Players (2020-2025)
3.2 Global Drug-Device Combination Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Drug-Device Combination Products Revenue
3.4 Global Drug-Device Combination Products Market Concentration Ratio
3.4.1 Global Drug-Device Combination Products Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug-Device Combination Products Revenue in 2024
3.5 Global Key Players of Drug-Device Combination Products Head office and Area Served
3.6 Global Key Players of Drug-Device Combination Products, Product and Application
3.7 Global Key Players of Drug-Device Combination Products, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug-Device Combination Products Breakdown Data by Type
4.1 Global Drug-Device Combination Products Historic Market Size by Type (2020-2025)
4.2 Global Drug-Device Combination Products Forecasted Market Size by Type (2026-2031)
5 Drug-Device Combination Products Breakdown Data by Application
5.1 Global Drug-Device Combination Products Historic Market Size by Application (2020-2025)
5.2 Global Drug-Device Combination Products Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Drug-Device Combination Products Market Size (2020-2031)
6.2 North America Drug-Device Combination Products Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Drug-Device Combination Products Market Size by Country (2020-2025)
6.4 North America Drug-Device Combination Products Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug-Device Combination Products Market Size (2020-2031)
7.2 Europe Drug-Device Combination Products Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Drug-Device Combination Products Market Size by Country (2020-2025)
7.4 Europe Drug-Device Combination Products Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug-Device Combination Products Market Size (2020-2031)
8.2 Asia-Pacific Drug-Device Combination Products Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Drug-Device Combination Products Market Size by Region (2020-2025)
8.4 Asia-Pacific Drug-Device Combination Products Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug-Device Combination Products Market Size (2020-2031)
9.2 Latin America Drug-Device Combination Products Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Drug-Device Combination Products Market Size by Country (2020-2025)
9.4 Latin America Drug-Device Combination Products Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug-Device Combination Products Market Size (2020-2031)
10.2 Middle East & Africa Drug-Device Combination Products Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Drug-Device Combination Products Market Size by Country (2020-2025)
10.4 Middle East & Africa Drug-Device Combination Products Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Drug-Device Combination Products Introduction
11.1.4 GSK Revenue in Drug-Device Combination Products Business (2020-2025)
11.1.5 GSK Recent Development
11.2 Novo Nordisk
11.2.1 Novo Nordisk Company Details
11.2.2 Novo Nordisk Business Overview
11.2.3 Novo Nordisk Drug-Device Combination Products Introduction
11.2.4 Novo Nordisk Revenue in Drug-Device Combination Products Business (2020-2025)
11.2.5 Novo Nordisk Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Details
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Drug-Device Combination Products Introduction
11.3.4 Eli Lilly Revenue in Drug-Device Combination Products Business (2020-2025)
11.3.5 Eli Lilly Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Details
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Drug-Device Combination Products Introduction
11.4.4 AstraZeneca Revenue in Drug-Device Combination Products Business (2020-2025)
11.4.5 AstraZeneca Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Drug-Device Combination Products Introduction
11.5.4 Sanofi Revenue in Drug-Device Combination Products Business (2020-2025)
11.5.5 Sanofi Recent Development
11.6 Boston Scientific
11.6.1 Boston Scientific Company Details
11.6.2 Boston Scientific Business Overview
11.6.3 Boston Scientific Drug-Device Combination Products Introduction
11.6.4 Boston Scientific Revenue in Drug-Device Combination Products Business (2020-2025)
11.6.5 Boston Scientific Recent Development
11.7 Abbott
11.7.1 Abbott Company Details
11.7.2 Abbott Business Overview
11.7.3 Abbott Drug-Device Combination Products Introduction
11.7.4 Abbott Revenue in Drug-Device Combination Products Business (2020-2025)
11.7.5 Abbott Recent Development
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Company Details
11.8.2 Boehringer Ingelheim Business Overview
11.8.3 Boehringer Ingelheim Drug-Device Combination Products Introduction
11.8.4 Boehringer Ingelheim Revenue in Drug-Device Combination Products Business (2020-2025)
11.8.5 Boehringer Ingelheim Recent Development
11.9 Medtronic
11.9.1 Medtronic Company Details
11.9.2 Medtronic Business Overview
11.9.3 Medtronic Drug-Device Combination Products Introduction
11.9.4 Medtronic Revenue in Drug-Device Combination Products Business (2020-2025)
11.9.5 Medtronic Recent Development
11.10 Viatris
11.10.1 Viatris Company Details
11.10.2 Viatris Business Overview
11.10.3 Viatris Drug-Device Combination Products Introduction
11.10.4 Viatris Revenue in Drug-Device Combination Products Business (2020-2025)
11.10.5 Viatris Recent Development
11.11 3M
11.11.1 3M Company Details
11.11.2 3M Business Overview
11.11.3 3M Drug-Device Combination Products Introduction
11.11.4 3M Revenue in Drug-Device Combination Products Business (2020-2025)
11.11.5 3M Recent Development
11.12 Hisamitsu
11.12.1 Hisamitsu Company Details
11.12.2 Hisamitsu Business Overview
11.12.3 Hisamitsu Drug-Device Combination Products Introduction
11.12.4 Hisamitsu Revenue in Drug-Device Combination Products Business (2020-2025)
11.12.5 Hisamitsu Recent Development
11.13 Smith & Nephew
11.13.1 Smith & Nephew Company Details
11.13.2 Smith & Nephew Business Overview
11.13.3 Smith & Nephew Drug-Device Combination Products Introduction
11.13.4 Smith & Nephew Revenue in Drug-Device Combination Products Business (2020-2025)
11.13.5 Smith & Nephew Recent Development
11.14 Molnlycke
11.14.1 Molnlycke Company Details
11.14.2 Molnlycke Business Overview
11.14.3 Molnlycke Drug-Device Combination Products Introduction
11.14.4 Molnlycke Revenue in Drug-Device Combination Products Business (2020-2025)
11.14.5 Molnlycke Recent Development
11.15 Teleflex
11.15.1 Teleflex Company Details
11.15.2 Teleflex Business Overview
11.15.3 Teleflex Drug-Device Combination Products Introduction
11.15.4 Teleflex Revenue in Drug-Device Combination Products Business (2020-2025)
11.15.5 Teleflex Recent Development
11.16 BD
11.16.1 BD Company Details
11.16.2 BD Business Overview
11.16.3 BD Drug-Device Combination Products Introduction
11.16.4 BD Revenue in Drug-Device Combination Products Business (2020-2025)
11.16.5 BD Recent Development
11.17 Lepu Medical
11.17.1 Lepu Medical Company Details
11.17.2 Lepu Medical Business Overview
11.17.3 Lepu Medical Drug-Device Combination Products Introduction
11.17.4 Lepu Medical Revenue in Drug-Device Combination Products Business (2020-2025)
11.17.5 Lepu Medical Recent Development
11.18 MicroPort
11.18.1 MicroPort Company Details
11.18.2 MicroPort Business Overview
11.18.3 MicroPort Drug-Device Combination Products Introduction
11.18.4 MicroPort Revenue in Drug-Device Combination Products Business (2020-2025)
11.18.5 MicroPort Recent Development
11.19 Terumo
11.19.1 Terumo Company Details
11.19.2 Terumo Business Overview
11.19.3 Terumo Drug-Device Combination Products Introduction
11.19.4 Terumo Revenue in Drug-Device Combination Products Business (2020-2025)
11.19.5 Terumo Recent Development
11.20 B. Braun
11.20.1 B. Braun Company Details
11.20.2 B. Braun Business Overview
11.20.3 B. Braun Drug-Device Combination Products Introduction
11.20.4 B. Braun Revenue in Drug-Device Combination Products Business (2020-2025)
11.20.5 B. Braun Recent Development
11.21 Antares Pharma
11.21.1 Antares Pharma Company Details
11.21.2 Antares Pharma Business Overview
11.21.3 Antares Pharma Drug-Device Combination Products Introduction
11.21.4 Antares Pharma Revenue in Drug-Device Combination Products Business (2020-2025)
11.21.5 Antares Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Medtronic Inc
Boston Scientific
BD
Teleflex
Terumo
GSK
Novo Nordisk
Eli Lilly
Astrazeneca plc
Sanofi
Abbott
Boehringer Ingelheim
3M
Hisamitsu
Smith & Nephew
Molnlycke
Lepu Medical
MicroPort
B. Braun
Antares Pharma
Viatris
List of Tables
 Table 1. Global Drug-Device Combination Products Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Drug-Coated Device
 Table 3. Key Players of Prefilled Drug Delivery Systems
 Table 4. Key Players of Nebulizer and Inhaler
 Table 5. Key Players of Transdermal Delivery System
 Table 6. Key Players of Others
 Table 7. Global Drug-Device Combination Products Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Drug-Device Combination Products Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Drug-Device Combination Products Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Drug-Device Combination Products Market Share by Region (2020-2025)
 Table 11. Global Drug-Device Combination Products Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Drug-Device Combination Products Market Share by Region (2026-2031)
 Table 13. Drug-Device Combination Products Market Trends
 Table 14. Drug-Device Combination Products Market Drivers
 Table 15. Drug-Device Combination Products Market Challenges
 Table 16. Drug-Device Combination Products Market Restraints
 Table 17. Global Drug-Device Combination Products Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Drug-Device Combination Products Market Share by Players (2020-2025)
 Table 19. Global Top Drug-Device Combination Products Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug-Device Combination Products as of 2024)
 Table 20. Ranking of Global Top Drug-Device Combination Products Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Drug-Device Combination Products Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Drug-Device Combination Products, Headquarters and Area Served
 Table 23. Global Key Players of Drug-Device Combination Products, Product and Application
 Table 24. Global Key Players of Drug-Device Combination Products, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Drug-Device Combination Products Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Drug-Device Combination Products Revenue Market Share by Type (2020-2025)
 Table 28. Global Drug-Device Combination Products Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Drug-Device Combination Products Revenue Market Share by Type (2026-2031)
 Table 30. Global Drug-Device Combination Products Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Drug-Device Combination Products Revenue Market Share by Application (2020-2025)
 Table 32. Global Drug-Device Combination Products Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Drug-Device Combination Products Revenue Market Share by Application (2026-2031)
 Table 34. North America Drug-Device Combination Products Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Drug-Device Combination Products Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Drug-Device Combination Products Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Drug-Device Combination Products Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Drug-Device Combination Products Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Drug-Device Combination Products Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Drug-Device Combination Products Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Drug-Device Combination Products Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Drug-Device Combination Products Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Drug-Device Combination Products Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Drug-Device Combination Products Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Drug-Device Combination Products Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Drug-Device Combination Products Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Drug-Device Combination Products Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Drug-Device Combination Products Market Size by Country (2026-2031) & (US$ Million)
 Table 49. GSK Company Details
 Table 50. GSK Business Overview
 Table 51. GSK Drug-Device Combination Products Product
 Table 52. GSK Revenue in Drug-Device Combination Products Business (2020-2025) & (US$ Million)
 Table 53. GSK Recent Development
 Table 54. Novo Nordisk Company Details
 Table 55. Novo Nordisk Business Overview
 Table 56. Novo Nordisk Drug-Device Combination Products Product
 Table 57. Novo Nordisk Revenue in Drug-Device Combination Products Business (2020-2025) & (US$ Million)
 Table 58. Novo Nordisk Recent Development
 Table 59. Eli Lilly Company Details
 Table 60. Eli Lilly Business Overview
 Table 61. Eli Lilly Drug-Device Combination Products Product
 Table 62. Eli Lilly Revenue in Drug-Device Combination Products Business (2020-2025) & (US$ Million)
 Table 63. Eli Lilly Recent Development
 Table 64. AstraZeneca Company Details
 Table 65. AstraZeneca Business Overview
 Table 66. AstraZeneca Drug-Device Combination Products Product
 Table 67. AstraZeneca Revenue in Drug-Device Combination Products Business (2020-2025) & (US$ Million)
 Table 68. AstraZeneca Recent Development
 Table 69. Sanofi Company Details
 Table 70. Sanofi Business Overview
 Table 71. Sanofi Drug-Device Combination Products Product
 Table 72. Sanofi Revenue in Drug-Device Combination Products Business (2020-2025) & (US$ Million)
 Table 73. Sanofi Recent Development
 Table 74. Boston Scientific Company Details
 Table 75. Boston Scientific Business Overview
 Table 76. Boston Scientific Drug-Device Combination Products Product
 Table 77. Boston Scientific Revenue in Drug-Device Combination Products Business (2020-2025) & (US$ Million)
 Table 78. Boston Scientific Recent Development
 Table 79. Abbott Company Details
 Table 80. Abbott Business Overview
 Table 81. Abbott Drug-Device Combination Products Product
 Table 82. Abbott Revenue in Drug-Device Combination Products Business (2020-2025) & (US$ Million)
 Table 83. Abbott Recent Development
 Table 84. Boehringer Ingelheim Company Details
 Table 85. Boehringer Ingelheim Business Overview
 Table 86. Boehringer Ingelheim Drug-Device Combination Products Product
 Table 87. Boehringer Ingelheim Revenue in Drug-Device Combination Products Business (2020-2025) & (US$ Million)
 Table 88. Boehringer Ingelheim Recent Development
 Table 89. Medtronic Company Details
 Table 90. Medtronic Business Overview
 Table 91. Medtronic Drug-Device Combination Products Product
 Table 92. Medtronic Revenue in Drug-Device Combination Products Business (2020-2025) & (US$ Million)
 Table 93. Medtronic Recent Development
 Table 94. Viatris Company Details
 Table 95. Viatris Business Overview
 Table 96. Viatris Drug-Device Combination Products Product
 Table 97. Viatris Revenue in Drug-Device Combination Products Business (2020-2025) & (US$ Million)
 Table 98. Viatris Recent Development
 Table 99. 3M Company Details
 Table 100. 3M Business Overview
 Table 101. 3M Drug-Device Combination Products Product
 Table 102. 3M Revenue in Drug-Device Combination Products Business (2020-2025) & (US$ Million)
 Table 103. 3M Recent Development
 Table 104. Hisamitsu Company Details
 Table 105. Hisamitsu Business Overview
 Table 106. Hisamitsu Drug-Device Combination Products Product
 Table 107. Hisamitsu Revenue in Drug-Device Combination Products Business (2020-2025) & (US$ Million)
 Table 108. Hisamitsu Recent Development
 Table 109. Smith & Nephew Company Details
 Table 110. Smith & Nephew Business Overview
 Table 111. Smith & Nephew Drug-Device Combination Products Product
 Table 112. Smith & Nephew Revenue in Drug-Device Combination Products Business (2020-2025) & (US$ Million)
 Table 113. Smith & Nephew Recent Development
 Table 114. Molnlycke Company Details
 Table 115. Molnlycke Business Overview
 Table 116. Molnlycke Drug-Device Combination Products Product
 Table 117. Molnlycke Revenue in Drug-Device Combination Products Business (2020-2025) & (US$ Million)
 Table 118. Molnlycke Recent Development
 Table 119. Teleflex Company Details
 Table 120. Teleflex Business Overview
 Table 121. Teleflex Drug-Device Combination Products Product
 Table 122. Teleflex Revenue in Drug-Device Combination Products Business (2020-2025) & (US$ Million)
 Table 123. Teleflex Recent Development
 Table 124. BD Company Details
 Table 125. BD Business Overview
 Table 126. BD Drug-Device Combination Products Product
 Table 127. BD Revenue in Drug-Device Combination Products Business (2020-2025) & (US$ Million)
 Table 128. BD Recent Development
 Table 129. Lepu Medical Company Details
 Table 130. Lepu Medical Business Overview
 Table 131. Lepu Medical Drug-Device Combination Products Product
 Table 132. Lepu Medical Revenue in Drug-Device Combination Products Business (2020-2025) & (US$ Million)
 Table 133. Lepu Medical Recent Development
 Table 134. MicroPort Company Details
 Table 135. MicroPort Business Overview
 Table 136. MicroPort Drug-Device Combination Products Product
 Table 137. MicroPort Revenue in Drug-Device Combination Products Business (2020-2025) & (US$ Million)
 Table 138. MicroPort Recent Development
 Table 139. Terumo Company Details
 Table 140. Terumo Business Overview
 Table 141. Terumo Drug-Device Combination Products Product
 Table 142. Terumo Revenue in Drug-Device Combination Products Business (2020-2025) & (US$ Million)
 Table 143. Terumo Recent Development
 Table 144. B. Braun Company Details
 Table 145. B. Braun Business Overview
 Table 146. B. Braun Drug-Device Combination Products Product
 Table 147. B. Braun Revenue in Drug-Device Combination Products Business (2020-2025) & (US$ Million)
 Table 148. B. Braun Recent Development
 Table 149. Antares Pharma Company Details
 Table 150. Antares Pharma Business Overview
 Table 151. Antares Pharma Drug-Device Combination Products Product
 Table 152. Antares Pharma Revenue in Drug-Device Combination Products Business (2020-2025) & (US$ Million)
 Table 153. Antares Pharma Recent Development
 Table 154. Research Programs/Design for This Report
 Table 155. Key Data Information from Secondary Sources
 Table 156. Key Data Information from Primary Sources
 Table 157. Authors List of This Report


List of Figures
 Figure 1. Drug-Device Combination Products Picture
 Figure 2. Global Drug-Device Combination Products Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Drug-Device Combination Products Market Share by Type: 2024 VS 2031
 Figure 4. Drug-Coated Device Features
 Figure 5. Prefilled Drug Delivery Systems Features
 Figure 6. Nebulizer and Inhaler Features
 Figure 7. Transdermal Delivery System Features
 Figure 8. Others Features
 Figure 9. Global Drug-Device Combination Products Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Drug-Device Combination Products Market Share by Application: 2024 VS 2031
 Figure 11. Hospital andClinic Case Studies
 Figure 12. Retail Pharmacies Case Studies
 Figure 13. Other Case Studies
 Figure 14. Drug-Device Combination Products Report Years Considered
 Figure 15. Global Drug-Device Combination Products Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Drug-Device Combination Products Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Drug-Device Combination Products Market Share by Region: 2024 VS 2031
 Figure 18. Global Drug-Device Combination Products Market Share by Players in 2024
 Figure 19. Global Top Drug-Device Combination Products Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug-Device Combination Products as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Drug-Device Combination Products Revenue in 2024
 Figure 21. North America Drug-Device Combination Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Drug-Device Combination Products Market Share by Country (2020-2031)
 Figure 23. United States Drug-Device Combination Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Drug-Device Combination Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Drug-Device Combination Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Drug-Device Combination Products Market Share by Country (2020-2031)
 Figure 27. Germany Drug-Device Combination Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Drug-Device Combination Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Drug-Device Combination Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Drug-Device Combination Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Drug-Device Combination Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Drug-Device Combination Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Drug-Device Combination Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Drug-Device Combination Products Market Share by Region (2020-2031)
 Figure 35. China Drug-Device Combination Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Drug-Device Combination Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Drug-Device Combination Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Drug-Device Combination Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Drug-Device Combination Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Drug-Device Combination Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Drug-Device Combination Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Drug-Device Combination Products Market Share by Country (2020-2031)
 Figure 43. Mexico Drug-Device Combination Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Drug-Device Combination Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Drug-Device Combination Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Drug-Device Combination Products Market Share by Country (2020-2031)
 Figure 47. Turkey Drug-Device Combination Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Drug-Device Combination Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Drug-Device Combination Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. GSK Revenue Growth Rate in Drug-Device Combination Products Business (2020-2025)
 Figure 51. Novo Nordisk Revenue Growth Rate in Drug-Device Combination Products Business (2020-2025)
 Figure 52. Eli Lilly Revenue Growth Rate in Drug-Device Combination Products Business (2020-2025)
 Figure 53. AstraZeneca Revenue Growth Rate in Drug-Device Combination Products Business (2020-2025)
 Figure 54. Sanofi Revenue Growth Rate in Drug-Device Combination Products Business (2020-2025)
 Figure 55. Boston Scientific Revenue Growth Rate in Drug-Device Combination Products Business (2020-2025)
 Figure 56. Abbott Revenue Growth Rate in Drug-Device Combination Products Business (2020-2025)
 Figure 57. Boehringer Ingelheim Revenue Growth Rate in Drug-Device Combination Products Business (2020-2025)
 Figure 58. Medtronic Revenue Growth Rate in Drug-Device Combination Products Business (2020-2025)
 Figure 59. Viatris Revenue Growth Rate in Drug-Device Combination Products Business (2020-2025)
 Figure 60. 3M Revenue Growth Rate in Drug-Device Combination Products Business (2020-2025)
 Figure 61. Hisamitsu Revenue Growth Rate in Drug-Device Combination Products Business (2020-2025)
 Figure 62. Smith & Nephew Revenue Growth Rate in Drug-Device Combination Products Business (2020-2025)
 Figure 63. Molnlycke Revenue Growth Rate in Drug-Device Combination Products Business (2020-2025)
 Figure 64. Teleflex Revenue Growth Rate in Drug-Device Combination Products Business (2020-2025)
 Figure 65. BD Revenue Growth Rate in Drug-Device Combination Products Business (2020-2025)
 Figure 66. Lepu Medical Revenue Growth Rate in Drug-Device Combination Products Business (2020-2025)
 Figure 67. MicroPort Revenue Growth Rate in Drug-Device Combination Products Business (2020-2025)
 Figure 68. Terumo Revenue Growth Rate in Drug-Device Combination Products Business (2020-2025)
 Figure 69. B. Braun Revenue Growth Rate in Drug-Device Combination Products Business (2020-2025)
 Figure 70. Antares Pharma Revenue Growth Rate in Drug-Device Combination Products Business (2020-2025)
 Figure 71. Bottom-up and Top-down Approaches for This Report
 Figure 72. Data Triangulation
 Figure 73. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Ophthalmic Combination Product Market Research Report 2024
Global Pharmaceutical and Medical Device Testing Market Research Report 2024
Global Combination Therapy Drug Market Research Report 2025
Global Ophthalmic Devices and Drugs Market Research Report 2025
Global Biologic Device Combination Products Market Research Report 2025
Global Drug device Combination Medical Device Market Research Report 2024
Global MedTech Devices Market Research Report 2025
Global Medical Device and Diagnostics Market Research Report 2025
Global Medicine Delivery Devices Market Research Report 2024
Global Pharmaceutical Drug Delivery Devices Market Insights Forecast to 2030
Global Diabetes Care Devices Drugs Market Research Report 2024
Combination Inhaler Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Medical Device Couplings Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Diabetes Care Combination Products Market Research Report 2025
Integrated Drug Containment and Delivery Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global On body Drug Delivery Devices Market Research Report 2025
Analytical Instruments for Drug Screening Market
Global Medical Equipment Market Research Report 2025
Drug Screening Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global High Throughput Drug Screening Equipment Market Research Report 2025

RELATED REPORTS

Global Surgical Waste Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16G6108
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global PET-CT Scanning Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27Q5892
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Micromanipulation Pipettes for IVF Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14K19926
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Nebulizer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15N17310
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions